江中药业
(600750)
| 流通市值：166.73亿 | | | 总市值：167.78亿 |
| 流通股本：6.25亿 | | | 总股本：6.29亿 |
| 报告期 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 1,227,404,483.82 | 4,390,101,978.99 | 3,140,059,049.17 | 2,297,549,382.03 |
| 营业收入 | 1,227,404,483.82 | 4,390,101,978.99 | 3,140,059,049.17 | 2,297,549,382.03 |
| 二、营业总成本 | 899,421,405.12 | 3,497,962,463.13 | 2,457,081,263.02 | 1,783,879,936.17 |
| 营业成本 | 383,292,218.02 | 1,523,006,427.15 | 1,014,237,916.77 | 735,414,641.29 |
| 税金及附加 | 17,708,509.11 | 62,645,765.58 | 45,991,018.33 | 31,654,741.5 |
| 销售费用 | 451,228,957.44 | 1,628,162,038.52 | 1,225,382,149.73 | 905,361,188.64 |
| 管理费用 | 39,863,057.4 | 210,620,085.49 | 143,908,457.09 | 92,204,892.49 |
| 研发费用 | 28,615,257.33 | 133,333,091.79 | 70,843,909.82 | 45,747,272.96 |
| 财务费用 | -21,286,594.18 | -59,804,945.4 | -43,282,188.72 | -26,502,800.71 |
| 其中:利息费用 | 16,803.02 | 6,979,911.38 | 3,869,792.01 | 3,421,594.84 |
| 其中:利息收入 | 21,410,096.41 | 67,639,194.53 | 47,841,751.37 | 30,114,662.77 |
| 加:公允价值变动收益 | 620,293.38 | -37,108,486.56 | 5,703,543.73 | 17,209,180.43 |
| 加:投资收益 | -156,921.56 | -2,937,648.04 | 953,690.05 | -158,589.57 |
| 资产处置收益 | 43,743.8 | 1,219,015.36 | 5,728.98 | 5,238.73 |
| 资产减值损失(新) | -8,220,500.98 | -8,853,990.82 | 4,951.72 | 4,951.72 |
| 信用减值损失(新) | 11,402,459.62 | -1,025,349.66 | 7,126,223.59 | 5,023,051.43 |
| 其他收益 | 3,543,342.56 | 50,682,589.92 | 29,840,914.98 | 20,786,439.27 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 335,215,495.52 | 894,115,646.06 | 726,612,839.2 | 556,539,717.87 |
| 加:营业外收入 | 1,196,329.57 | 9,069,320.81 | 7,906,205.89 | 5,416,453.31 |
| 减:营业外支出 | 356,695.07 | 6,051,321.83 | 1,357,511.82 | 902,478.78 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 336,055,130.02 | 897,133,645.04 | 733,161,533.27 | 561,053,692.4 |
| 减:所得税费用 | 51,509,994.17 | 130,469,998.14 | 108,491,147.38 | 86,917,062.73 |
| 六、净利润 | 284,545,135.85 | 766,663,646.9 | 624,670,385.89 | 474,136,629.67 |
| 持续经营净利润 | 284,545,135.85 | 766,663,646.9 | 624,670,385.89 | 474,136,629.67 |
| 归属于母公司股东的净利润 | 266,779,517.36 | 708,291,520.66 | 589,476,536.94 | 447,001,834.46 |
| 少数股东损益 | 17,765,618.49 | 58,372,126.24 | 35,193,848.95 | 27,134,795.21 |
| (一)基本每股收益 | 0.43 | 1.12 | 0.93 | 0.7 |
| (二)稀释每股收益 | 0.43 | 1.12 | 0.93 | 0.7 |
| 九、综合收益总额 | 284,545,135.85 | 766,663,646.9 | 624,670,385.89 | 474,136,629.67 |
| 归属于母公司股东的综合收益总额 | 266,779,517.36 | 708,291,520.66 | 589,476,536.94 | 447,001,834.46 |
| 归属于少数股东的综合收益总额 | 17,765,618.49 | 58,372,126.24 | 35,193,848.95 | 27,134,795.21 |
| 公告日期 | 2024-04-27 | 2024-03-23 | 2023-10-28 | 2023-08-24 |
| 审计意见(境内) | | 标准无保留意见 | | |